Skip to main content

Affibody, InforSense, BSI Proteomics, Michael Barber Centre for Mass Spectrometry

Premium

Affibody of Stockholm and InforSense of London have released KDE GeneSense, a program for interpreting experimental genomics, transcriptomics, and proteomics data with available scientific knowledge. GeneSense couples Infor- Sense’s Kensington Discovery Edition (KDE) informatics environment with Affibody’s data management, biological annotation, and visual representation technology.

 

BSI Proteomics of Gaithersburg, Md., has launched ARD FivePack, a protein crystalllization system that is based on BSI’s Automated Robotic Dynamic Crystalization System, which can crystallize proteins in 100 different chambers at 100 different conditions simultaneously using 2 ml of protein in each chamber. The ARD FivePack allows to set up five different proteins for crystallization and can be set up in less than one hour, according to the company.

 

The PBIL Lyon-Gerland in France has made available SuMo, a system for extracting structural and possibly functional similarities in three-dimensional structures of proteins, though a web interface at http://sumo-pbil.ibcp.fr. The interface allows users to screen a database of 11,500 ligand binding sites with a given protein structure or substructure, and to screen the PDB with a given ligand binding site. SuMo is based on a description of three-dimensional structures of macromolecules using various types of chemical groups with specific geometry, symmetry, and parameters.

 

The Michael Barber Centre for Mass Spectrometry is holding a course,“Mass Spectrometry for Protein & Peptide scientists” at the University of Manchester Institute for Science and Technology from June 30th -July 3rd. The course, sponsored by Waters, will provide a practical introduction to the analysis of proteins by mass spectrometry. For more information, see www.ch.umist.ac.uk/cms/courses/courses.html or www.micromass.co.uk/umist.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.